THE IMPACT OF COVID-19 ON POPULATION-LEVEL DRUG UTILIZATION OF ALENDRONATE
Tan EH., Robinson D., Jodicke A., Mosseveld M., Nielsen KB., Reyes C., Voss A., Marconi E., Lapi F., Reinold J., Verhamme K., Pedersen L., De Wilde M., Far M., Aragon M., Bosco-Levy P., Lassalle R., Prieto-Alhambra D.